Medicare Enrolled

Dr. Michael Caglia, M.D.

Internal Medicine · Midland, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
4214 ANDREWS HWY, Midland, TX 79703
4326892491
In practice since 2010 (15 years)
NPI: 1568789550 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Caglia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Caglia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Caglia

Dr. Michael Caglia is an internal medicine specialist in Midland, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Caglia performed 5,518 Medicare services across 2,126 unique beneficiaries.

Between the years covered by Open Payments, Dr. Caglia received a total of $315,532 from 36 pharmaceutical and/or device companies across 762 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Caglia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 6% volume in TX $315,532 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,518
Medicare services
Top 6% in TX for internal medicine
2,126
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~368 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 1,307 $5 $12
Ultrasonic guidance for placement of radiation therapy fields 639 $134 $313
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area 620 $201 $468
Office visit, established patient (20-29 min) 601 $56 $158
Superficial and/or low voltage radiation treatment delivery 597 $30 $71
Destruction of precancerous skin growth, 1 380 $33 $117
Destruction of skin growths (warts/lesions), 1-14 291 $77 $199
Skin biopsy, tangential 182 $61 $178
New patient office visit (30-44 min) 178 $66 $195
Radiation treatment management, 5 treatment sessions 116 $145 $336
Office visit, established patient (10-19 min) 110 $37 $99
Continuing radiation therapy consultation per week 83 $65 $149
Calculation of radiation therapy dose 61 $49 $115
Office visit, established patient (30-39 min) 57 $84 $223
Steroid injection (triamcinolone) 41 $1 $2
Injection into skin growth, 1-7 growths 40 $34 $100
New patient office or other outpatient visit, 15-29 minutes 40 $44 $126
Biopsy of related skin growth, each additional growth 35 $38 $88
Simple radiation therapy planning 25 $53 $124
Design and construction of complex radiation treatment device 23 $91 $212
Destruction of precancer skin growth, 15 or more growths 22 $128 $296
Design and construction of simple radiation treatment device 19 $29 $67
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm 14 $210 $532
Biopsy of ear 13 $45 $169
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm 12 $92 $428
New patient office visit (45-59 min) 12 $87 $291
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$315,532
Total received (2018-2024)
Avg $45,076/year across 7 years
Top 1% in TX for internal medicine
36
Companies
762
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$305,733 (96.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,799 (3.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,104
2023
$2,469
2022
$7,701
2021
$56,862
2020
$64,306
2019
$86,594
2018
$95,497

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$142,097
Janssen Scientific Affairs, LLC
$69,440
Amgen Inc.
$33,942
Sun Pharmaceutical Industries Inc.
$32,451
SUN PHARMACEUTICAL INDUSTRIES INC.
$27,952
AbbVie Inc.
$1,205
Novartis Pharmaceuticals Corporation
$1,078
E.R. Squibb & Sons, L.L.C.
$777
ABBVIE INC.
$754
Incyte Corporation
$674
MAYNE PHARMA INC.
$508
Lilly USA, LLC
$415
Mayne Pharma Inc.
$395
Arcutis Biotherapeutics, Inc.
$375
Regeneron Healthcare Solutions, Inc.
$363
Dermavant Sciences, Inc.
$356
Janssen Biotech, Inc.
$319
UCB, Inc.
$270
LEO Pharma Inc.
$266
PFIZER INC.
$251
Journey Medical Corporation
$241
Galderma Laboratories, L.P.
$230
MAYNE PHARMA COMMERCIAL LLC
$226
AbbVie, Inc.
$196
GENZYME CORPORATION
$188
Biofrontera Inc.
$127
Allergan, Inc.
$121
Almirall LLC
$62
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
Genentech USA, Inc.
$50
Tactile Systems Technology Inc
$48
DUSA Pharmaceuticals, Inc.
$40
Ortho Dermatologics, a division of Bausch Health US, LLC
$20
DERMIRA, INC.
$18
Merck Sharp & Dohme LLC
$14
Bayer HealthCare Pharmaceuticals Inc.
$13
Top 3 companies account for 77.8% of total payments
Associated products mentioned in payments ›
20% · ABSORICA LD · ADBRY · AKLIEF · AMELUZ · Absorica LD · Ameluz · BOTOX · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · FINACEA · Finacea · Flexitouch Plus · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · KEYTRUDA · Klisyri · LEVULAN KERASTICK · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · OPZELURA · ORACEA · Odomzo · Otezla · QBREXZA · REMICADE · RINVOQ · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · TRILUMA · Tremfya · VTAMA · Winlevi · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for internal medicine in TX.

Equivalent to $5,718 per 100 Medicare services performed
Looking for an internal medicine specialist in Midland?
Compare internal medicine physicians in the Midland area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
110
Per 100K population
64.1
County median income
$93,984
Nearest hospital
MIDLAND MEMORIAL HOSPITAL
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Caglia is a clinical cardiology specialist, with above-average Medicare volume (top 6% in TX), with speaking/promotional industry engagement in the top 1% of TX peers, with 15 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Caglia experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Caglia performed 1,307 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Caglia receive payments from pharmaceutical companies?
Yes. Dr. Caglia received a total of $315,532 from 36 companies across 762 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Caglia's costs compare to other internal medicine physicians in Midland?
Dr. Caglia's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Caglia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →